(Q1)Oct 31, 2024 | (FY)Jul 31, 2024 | (Q4)Jul 31, 2024 | (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | (Q1)Oct 31, 2023 | (FY)Jul 31, 2023 | (Q4)Jul 31, 2023 | (Q3)Apr 30, 2023 | (Q2)Jan 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -1,740.70%-517.74K | 50.93%-996.79K | -304.58%-359.4K | -99.88%-361.83K | 70.28%-247.44K | 96.97%-28.13K | -214.24%-2.03M | 89.58%-88.83K | 93.13%-181.02K | 69.40%-832.59K |
Net income from continuing operations | -201.04%-299.34K | 99.89%-14.35K | 21.96%-1.02M | 107.18%203.86K | 108.33%504.11K | 112.61%296.27K | -4.01%-12.55M | 75.52%-1.31M | 68.46%-2.84M | -72.93%-6.05M |
Operating gains losses | ---- | -195.78%-206.36K | ---- | ---- | ---- | ---- | -41.26%215.46K | -118.98%-145.54K | 4,052.71%360.66K | 91.80%-86 |
Depreciation and amortization | --0 | -72.15%112.19K | 9.78%44.84K | -63.31%40.64K | -95.08%6.27K | -83.51%20.44K | 66.93%402.89K | -63.56%40.84K | 54.10%110.79K | 123.27%127.3K |
Asset impairment expenditure | ---- | -89.36%702.53K | -42.27%702.53K | --0 | ---- | ---- | 60.85%6.6M | -70.35%1.22M | --1.9M | ---- |
Remuneration paid in stock | -96.78%2.85K | -100.34%-8.82K | -94.00%9.21K | -86.90%16.11K | -110.34%-122.53K | -92.00%88.4K | -57.01%2.57M | -82.28%153.49K | -97.51%123.03K | 761.18%1.18M |
Other non cashItems | ---- | -58.01%100.27K | 513.92%209.06K | -353.91%-150.14K | -41.00%24.66K | -83.93%16.68K | -87.97%238.79K | 120.17%34.05K | -92.44%59.13K | -95.31%41.79K |
Change In working capital | 50.83%-221.24K | -443.63%-1.68M | -19.93%-100.08K | -614.94%-558.76K | -251.72%-573.5K | -620.06%-449.92K | 4,634.61%489.56K | -236.67%-83.45K | -80.67%108.51K | 223.73%377.99K |
-Change in receivables | -110.25%-13.34K | -91.17%9.26K | 572.42%60.57K | -161.26%-41.12K | -109.14%-3.85K | -175.02%-6.34K | 148.91%104.92K | 40.76%-12.82K | 157.53%67.11K | 169.91%42.18K |
-Change in prepaid assets | -16.76%11.12K | -77.48%58.87K | -98.18%3.88K | 100.62%48.74K | 77.64%-7.1K | -75.87%13.36K | 185.13%261.43K | 15.69%213.53K | -28.00%24.29K | 90.43%-31.76K |
-Change in payables and accrued expense | -322.86%-219.02K | -79.86%99.28K | -76.57%20.83K | -167.89%-11.61K | -102.24%-8.22K | 404.58%98.28K | -19.01%493.06K | 187.28%88.91K | -97.63%17.1K | 323.17%367.57K |
-Change in other working capital | ---- | -400.12%-1.85M | 50.31%-185.37K | -27,738,450.00%-554.77K | ---554.32K | -17,364.09%-555.21K | -381.33%-369.85K | -5,329,371.43%-373.06K | --2 | --0 |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -1,740.70%-517.74K | 50.93%-996.79K | -304.58%-359.4K | -99.88%-361.83K | 70.28%-247.44K | 96.97%-28.13K | -214.24%-2.03M | 89.58%-88.83K | 93.13%-181.02K | 69.40%-832.59K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 0 | 0 | 0 | 112.23%352.85K | 110.30%34.97K | 99.90%-1.62K | 89.25%-107.1K | |||
Net intangibles purchas and sale | ---- | --0 | --0 | --0 | ---- | ---- | 75.58%-451.34K | 108.62%34.97K | 99.89%-1.35K | 48.00%-107.1K |
Net business purchase and sale | ---- | --0 | --0 | --0 | ---- | ---- | 256.53%804.19K | --0 | ---268 | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | ---- | --0 | --0 | --0 | ---- | ---- | 112.23%352.85K | 110.30%34.97K | 99.90%-1.62K | 89.25%-107.1K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 613.95%335.56K | 26.77%1.85M | 2,772.82%926.63K | 11.45%-27.5K | -15.67%903.5K | -87.84%47K | -62.20%1.46M | 166.66%32.26K | -367.34%-31.06K | -55.58%1.07M |
Net issuance payments of debt | -820.36%-86.44K | -115.81%-175.87K | -226.71%-40.87K | -173.70%-85K | -108.55%-62K | -96.89%12K | 673.31%1.11M | 166.66%32.26K | 35.81%-31.06K | 2,349.31%725.54K |
Net common stock issuance | ---- | --1M | --0 | --0 | ---- | ---- | --0 | --0 | --0 | ---- |
Proceeds from stock option exercised by employees | --412K | 195.67%1.03M | --967.5K | 5,750,100.00%57.5K | --0 | --0 | 477.78%346.67K | --0 | -100.00%-1 | --345.83K |
Net other financing activities | -71.43%10K | ---- | ---- | ---- | ---- | --35K | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 613.95%335.56K | 26.77%1.85M | 2,772.82%926.63K | 11.45%-27.5K | -15.67%903.5K | -87.84%47K | -62.20%1.46M | 166.66%32.26K | -367.34%-31.06K | -55.58%1.07M |
Net cash flow | ||||||||||
Beginning cash position | 1,815.36%899.82K | -84.75%46.98K | 384.92%332.58K | 155.74%721.91K | -65.85%65.85K | -84.75%46.98K | 12,514.05%308.04K | -95.63%68.59K | -95.18%282.28K | -97.31%192.84K |
Current changes in cash | -1,065.28%-182.18K | 488.27%852.84K | 2,725.84%567.23K | -82.18%-389.33K | 398.23%656.06K | 116.27%18.87K | -167.05%-219.65K | 98.26%-21.6K | 95.01%-213.7K | 110.09%131.68K |
Effect of exchange rate changes | ---- | --0 | --0 | --0 | ---- | ---- | -88.22%-41.4K | 99.98%-4 | --2 | ---42.23K |
End cash Position | 989.78%717.64K | 1,815.36%899.82K | 1,815.36%899.82K | 384.92%332.58K | 155.74%721.91K | -65.85%65.85K | -84.75%46.98K | -84.75%46.98K | -95.63%68.59K | -95.18%282.28K |
Free cash from | -1,740.70%-517.74K | 59.85%-996.79K | -567.31%-359.4K | -98.40%-361.83K | 73.67%-247.44K | 97.85%-28.13K | 17.24%-2.48M | 95.81%-53.86K | 95.76%-182.38K | 68.32%-939.7K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data